Page last updated: 2024-08-25

coptisine and Esophageal Neoplasms

coptisine has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Liu, C; Qu, S; Wen, X; Yang, Y; Zhang, X	1

Other Studies

1 other study(ies) available for coptisine and Esophageal Neoplasms

Article	Year
Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway. Die Pharmazie, 2021, 05-01, Volume: 76, Issue:5 Topics: Antineoplastic Agents; Berberine; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Claudin-2; Cyclin B1; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrroles; Signal Transduction	2021

Article

Year

Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway.

Die Pharmazie, 2021, 05-01, Volume: 76, Issue:5

Topics: Antineoplastic Agents; Berberine; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Claudin-2; Cyclin B1; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrroles; Signal Transduction

2021